Literature DB >> 11959675

HPA-axis responses during experimental colitis in the rat.

Kensaku Kojima1, Yoshihisa Naruse, Norio Iijima, Naoki Wakabayashi, Shoji Mitsufuji, Yasuhiko Ibata, Masaki Tanaka.   

Abstract

We investigated the responses of the hypothalamic-pituitary-adrenal (HPA) axis during experimental colitis induced by intracolonic administration of 2,4,6-trinitrobenzenesulfonic acid in the rat. On days 3 and 7 after induction of colitis, the corticotropin-releasing hormone (CRH) mRNA level in the parvocellular paraventricular nucleus (pPVN) of the hypothalamus was reduced, the plasma ACTH level remained at the basal level, and the plasma corticosterone (Cort) level was high. Induction of colitis on day 3 after adrenalectomy with Cort pellet replacement (ADX + Cort) resulted in a marked increase in CRH mRNA on day 7 after induction of colitis compared with noncolitic ADX + Cort animals. Pair feeding to match the food intake of the colitic animals resulted in no significant change in CRH mRNA in the pPVN, plasma ACTH, and Cort compared with healthy control animals. These findings indicated that CRH mRNA expression in the pPVN was inhibited by glucocorticoid feedback during this experimental colitis, and the decrease in food intake during colitis was not simply responsible for the expression of CRH mRNA. It is inferred that the HPA axis including the CRH level in the pPVN is altered in patients with inflammatory bowel disease.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11959675     DOI: 10.1152/ajpregu.00260.2001

Source DB:  PubMed          Journal:  Am J Physiol Regul Integr Comp Physiol        ISSN: 0363-6119            Impact factor:   3.619


  8 in total

Review 1.  Supraspinal Mechanisms of Intestinal Hypersensitivity.

Authors:  Olga A Lyubashina; Ivan B Sivachenko; Sergey S Panteleev
Journal:  Cell Mol Neurobiol       Date:  2020-10-08       Impact factor: 5.046

2.  Compromised neuroimmune status in rats with experimental colitis.

Authors:  Lysa Boissé; Marja D Van Sickle; Keith A Sharkey; Quentin J Pittman
Journal:  J Physiol       Date:  2003-03-14       Impact factor: 5.182

3.  Glutamate microinjection into the hypothalamic paraventricular nucleus attenuates ulcerative colitis in rats.

Authors:  Ting-ting Li; Jian-fu Zhang; Su-juan Fei; Sheng-ping Zhu; Jin-zhou Zhu; Xiao Qiao; Zhang-bo Liu
Journal:  Acta Pharmacol Sin       Date:  2013-12-23       Impact factor: 6.150

4.  Stress maladjustment in the pathoetiology of ulcerative colitis.

Authors:  Tsukasa Kuroki; Akihide Ohta; Yosuke Aoki; Seiji Kawasaki; Nozomi Sugimoto; Hibiki Ootani; Seiji Tsunada; Ryuichi Iwakiri; Kazuma Fujimoto
Journal:  J Gastroenterol       Date:  2007-07-25       Impact factor: 7.527

5.  Colitis causes delay in puberty in female mice out of proportion to changes in leptin and corticosterone.

Authors:  Mark D DeBoer; Yongli Li; Steven Cohn
Journal:  J Gastroenterol       Date:  2010-03       Impact factor: 7.527

6.  Comorbid anxiety-like behavior in a rat model of colitis is mediated by an upregulation of corticolimbic fatty acid amide hydrolase.

Authors:  Haley A Vecchiarelli; Maria Morena; Catherine M Keenan; Vincent Chiang; Kaitlyn Tan; Min Qiao; Kira Leitl; Alessia Santori; Quentin J Pittman; Keith A Sharkey; Matthew N Hill
Journal:  Neuropsychopharmacology       Date:  2021-01-15       Impact factor: 7.853

7.  Dextran sulfate sodium-induced colitis alters stress-associated behaviour and neuropeptide gene expression in the amygdala-hippocampus network of mice.

Authors:  Florian Reichmann; Ahmed Mostafa Hassan; Aitak Farzi; Piyush Jain; Rufina Schuligoi; Peter Holzer
Journal:  Sci Rep       Date:  2015-06-12       Impact factor: 4.379

8.  Essential Role of Growth Hormone and IGF-1 in Therapeutic Effect of Ghrelin in the Course of Acetic Acid-Induced Colitis.

Authors:  Piotr Ceranowicz; Zygmunt Warzecha; Jakub Cieszkowski; Dagmara Ceranowicz; Beata Kuśnierz-Cabala; Joanna Bonior; Jolanta Jaworek; Tadeusz Ambroży; Krzysztof Gil; Rafał Olszanecki; Małgorzata Pihut; Artur Dembiński
Journal:  Int J Mol Sci       Date:  2017-05-24       Impact factor: 5.923

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.